Login or create an accountClose
I am a returning customer
Login or create an accountClose
Your Account Has Been Created!
Thank you for registering with MedsDots!
You will be notified by e-mail once your account has been activated by the store owner.
If you have ANY questions about the operation of this online shop, please contact the store owner.
You have been logged off your account. It is now safe to leave the computer.
Your shopping cart has been saved, the items inside it will be restored whenever you log back into your account.
ponatinix ponatinib tablets
- Manufacturer BEACON PHARMACEUTICALS
- Product Code: Ponatinix
Brand Name: Ponatinix
International Brand Name: Iclusig
Active Ingredient: Ponatinib
Manufactured By: Beacon Pharmaceuticals Ltd.
Strength: 15mg & 45mg
Packing: Bottle (15mg contains 60 Tablets) & (45mg contains 30 Tablets)
* Bangladesh medicine is not for sale in India.
what is ponatinix tablet?
ponatinib is used in adults to treat a type of blood cancer called chronic myeloid leukemia (cml), or philadelphia chromosome-positive acute lymphoblastic leukemia (all).
it is suitable for the treatment of adult patients with chronic phase, accelerated phase, or blast phase chronic myelogenous leukemia (cml) who are resistant or intolerant to previous tyrosine kinase inhibitor treatments.
uses and dosage:
the recommended dose is 45mg, once a day, orally with or without food;
as long as there is no evidence of disease progression or unacceptable toxicity, treatment should be continued;
adjust the dose or interrupt the administration for haematological and non-haematological toxicity.
common adverse reactions:
the most common non-haematological adverse reactions (≥20%) are hypertension, skin rash, abdominal pain, fatigue, headache, dry skin, constipation, arthralgia, nausea, and fever. haematological adverse reactions include thrombocytopenia, anaemia, neutropenia, lymphopenia, and leukopenia.
use in special groups:
congestive heart failure: monitor the signs and symptoms of congestive heart failure in patients and treat them when clinical signs are available.
hypertension: monitor hypertension and treatment when clinically indicated.
pancreatitis: monitor serum esterase monthly; interrupt or terminate medication.
bleeding: discontinue medication for severe bleeding.
fluid retention: monitor patients for fluid retention, and should interrupt, or reduce the dose, or even stop taking the medication.
arrhythmia: monitor for symptoms of arrhythmia.
myelosuppression: thrombocytopenia, neutropenia, and anaemia may require interruption or dose reduction. monitor the complete cell count every two weeks for 3 months and then monthly and when clinically indicated. interrupt the medication for anc <1000/mm3 or thrombocytopenia <50000/mm3. tumour lysis syndrome: ensure hydration and correct high uric acid levels before starting treatment with pranatinib.
impaired wound healing and perforation of the gastrointestinal tract: temporary interruption of treatment in patients undergoing major surgery.
embryo-fetal toxicity: may cause harm to the fetus. advise women of the potential risks to the fetus.
how to find ponatinix tablets?
if you want to know the best way to find this medicine, then you should consult medsdots. it is an medicine retailer who is delivering medicines according to the requirement of the person. if have any query regarding this drug can call or send whatsapp on our customer care number +919953810074, wechat: medsdots, e-mail: firstname.lastname@example.org. we are the genuine and original oncology medicine supplier in india also supplies all around the world including china, hong kong, usa, russia, uk, malaysia, philippines, vietnam, hungary, romania, germany, cambodia, thailand, new zealand, fiji, laos, belarus, singapore, and many other countries.